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The aorta is innervated by the sympathetic nervous system that regulates its lumen and thereby affects the arterial blood pressure in the body. Norepinephrine released from the nerve endings binds mainly to á 1 -adrenergic receptors resulting in aortic muscle contraction (DOCHERTY et al.1979; DREW et al. 1979; GNUS et al. 2012) . In addition to the á-adrenergic receptors the blood vessel wall contains â-adrenergic receptors, stimulation of which initiates relaxation of vascular smooth muscle. The change in vascular reactivity after stimulation of â-adrenergic receptors may be associated with the development of hypertension (BORKOWSKI et al. 1992; OLIVER et al. 2009 ).
Originally vascular â-adrenergic receptors were classified as â 2 subtype (LANDS et al. 1967) , then it was proven that the â 1 subtype also takes parts in vasorelaxation (O'DONNEL et al. 1985) . Based on a number of functional in vitro studies carried out in subsequent years, the existence of atypical â-adrenergic receptors in the vascular wall was suggested (ORIOWO et al. 1994; BRAWLEY et al. 2000) .
Since the activation of â-adrenergic receptors is associated with relaxation response, the procedure used in in vitro experiments involves functional precontraction of the vessel strips. The substances usually used for this purpose are the á-agonists, particularly phenylephrine. However, we can not exclude the possibility that agonists and antagonists of â-adrenergic receptors are able to nonspecifically stimulate or block the á-adrenergic receptors or influence other pathways which play a role in vascular contractility. This paper focuses on the demonstration of nonspecific activity of â-adrenergic ligands not related to the stimulation or blocking of the â-adrenergic receptors, which may be associated, among others, with effects on á-adrenergic receptors as well as with pathways not involving the adrenergic system.
Material and Methods
The study was conducted on 30 New Zealand rabbits weighing 3-4 kg from which specimens of the abdominal aorta were collected. The study was approved by the II Local Ethical Committee, approval no. 89/2010.
The experimental animals were euthanized by administering intravenous solution of pentobarbiturate (Morbital). Immediately after death, 4-5 cm long specimens of abdominal aorta were collected and cut into 0.5 cm wide rings. The diameter of the aorta in New Zealand breed rabbits weighing 3-4 kg was on average 4 to 6 mm. Strips were set up in an automatic water bath in four chambers of 20 ml capacity. The samples were placed transversely by threading the surgical thread safil 4.0 inside the aorta lumen and mounted so that the changes of the isolate transverse section were registered. The initial tonus of all strips was 9.8 mN (ZIYAL et al. 1997) . This was the baseline value used as a reference for the obtained results. The time required to balance the record was determined experimentally at 60 minutes. Krebs-Henseleit buffer of the following composition was used as the incubation environment: NaCl -118 mM; KCl -4.7 mM; CaCl 2 -2.5 mM; MgSO 4 -1.6 mM; NaHCO 3 -24.3 mM; KH 2 PO 4 -1.18 mM; glucose 5.6 mM. Incubation of the strips was carried out at 37°C in a gaseous mixture of oxygen and carbon dioxide used in the following proportion: 95% of O 2 and 5% of CO 2 , in order to obtain a pH value of 7.3-7.5. Aortic contractions were registered with isotonic transducers (Letica Scientific Instruments) combined with bridge amplifiers (BridgeAmp, ADInstruments, Australia), and 4-channel data acquisition system (PowerLab/400, ADInstruments) connected to a Macintosh computer.
After the equilibration time the presence of functional endothelium was confirmed by the relaxation in response to acetylcholine (3·10 -6 M). Following washout, aortae were then contracted with cumulative doses of agonist (phenylephrine, isoproterenol, dobutamine or salbutamol) until a maximal response was reached or incubated with an antagonist for 30 min (propranolol or betaxolol, 2·10
-5 M). Concentration-response curves to agonists were constructed after preincubation with antagonists. Neither of the antagonists at a concentration of 2·10 -5 M caused inhibition of the reaction to increasing doses of the á 1 -adrenergic agonist phenylephrine (data not shown).
The following chemical substances were added: phenylephrine-á 1 -adrenergic receptor agonist (Sigma--Aldrich), isoproterenol -nonspecific â-adrenergic receptor agonist (Sigma-Aldrich), salbutamol -â 2 -adrenergic receptor agonist (Sigma-Aldrich), dobutamine -â 1 -adrenergic receptor agonist (Sigma--Aldrich), propranolol -â 1 and â 2 adrenergic receptor antagonist (Sigma-Aldrich), betaxolol -â 1 adrenergic receptor antagonist (Sigma-Aldrich).
We analysed the strength of contractions expressed in mN (contractility amplitude). The results of the tests expressed as mean and standard deviation (±SD) were processed with the use of Microsoft Office Excel 2000 spreadsheets and analysed statistically with Student's t-test and a single-factor analysis of variance (ANOVA) for independent variables.
Results

Phenylephrine
Application of phenylephrine to the incubation chamber induced contraction of the rabbit aorta strips (n=9) in a concentration dependent manner. A minimal reaction was observed at a phenylephrine concentration of 3·10 -7 M, while the maximum (7.61±1.47 mN) at a concentration of 3·10 -5 M; further increase of concentration did not intensify the contractile response ( Fig. 1 ). Log 10 EC 50 for phenylephrine was -5.85±0.22 (Fig. 2 ).
Dobutamine
Application of dobutamine to the incubation chamber induced contraction of the rabbit aorta strips in a concentration dependent manner (n=5). Minimal reaction (0.412±0.128 mN) was noted at a concentration of 3·10 -7 M, while the maximum (6.118±0.268 mN) at a concentration of 3·10 -5 M (Fig. 1A) . Log 10 EC 50 for dobutamine was equal to -6.22±0.17 (Fig. 1B) .
Isoproterenol
The minimum concentration of isoproterenol causing contraction of the rabbit aorta strips (n=5) was 3 · 10 -7 mol. Tissue tonus increased by 0.051±0.054 mN. The strongest reaction occurred at isoprenaline concentration of 3·10
-5 M and amounted to 1.625±0.094 mN (Fig. 1A) . Log 10 EC 50 for isoproterenol was equal to -5.66±0.2 (Fig. 1B) .
Salbutamol
High concentrations of salbutamol caused a slight increase in tonus of rabbit abdominal aortic rings (n=7). The lowest concentration at which the tissue contraction was visible was 3·10 -8 M, and the tonus increased up to 0.028 mN. The strongest reaction was observed at a concentration of 3 · 10 -5 M, and it amounted to 1.161±0.167 mN (Fig. 1A) . Log 10 EC 50 for salbutamol was -5.9±0.19 (Fig. 1B ).
Propranolol and Dobutamine
Pre-incubation of the rabbit abdominal aortic rings (n=5) in propranolol (2·10 -5 M) altered the tissue reaction to dobutamine. The contraction appeared at a dobutamine concentration of 3·10 -8 M, and the tone changed by 0.098 mN. Elevating the concentration of the agonist after preincubation in the antagonist induced a weaker reaction than while using the agonist alone. The maximum reaction was weaker and amounted to 1.161±0.167 mN, which accounted for 43.7% of the maximum response to dobutamine alone ( Fig. 2A) . The EC 50 value was higher and amounted to -5.75±0.25.
Betaxolol and Dobutamine
Pre-incubation of the rabbit abdominal aortic rings (n=8) in betaxolol (2·10 -5 M) had a similar effect as propranolol. Reaction to dobutamine appeared at a concentration of 3·10 -8 M and maximum contraction was weaker, 2.882±0.26 mN (47.11% of the maximum response elicited by an antagonist alone agonist alone).
Propranolol and Isoproterenol
Pre-incubation of the rabbit abdominal aortic rings (n=7) in propranolol (2·10 -5 M) altered the tissue reaction to isoproterenol. The addition of the antagonist to the buffer resulted in contractile reaction to the agonist at a concentration of 3·10 -8 M, and the tissue tone changed by 0.07 mN. The contractile reaction to isoproterenol concentrations of 3·10 -7 and 3·10 -6 M were also escalated. However, the tissue response to high concentrations of isoproterenol (3·10 -5 M) was slightly lower following the application of the antagonist and amounted to 1.596±0.139 mN (statistically insignificant). EC 50 for isoproterenol after preincubation in propra- nolol did not differ significantly from the EC 50 for the agonist alone (Fig. 2B ).
Betaxolol and Isoproterenol
Pretreatment of rabbit aortae rings (n=8) with betaxolol abolished the contractile reaction to isoproterenol at a concentration of 3·10 -7 M. The maximum reaction was weaker and amounted to 0.475±0.05 mN, which accounted for 29.23% of the maximum response to isoproterenol alone.
Propranolol and Salbutamol
Preincubation of rabbit abdominal aortic rings (n=5) in propranolol reduced the contractile reaction induced by salbutamol. Ring tonus changed by 0.076±0.049 mN only at a salbutamol concentration of 3·10 -6 M. The maximal reaction to salbutamol (3·10 -5 M) was weaker in the presence of propranolol and was 0.172±0.08 mN. EC 50 for salbutamol plus propranolol was -5.5±0.23 (Fig. 2C) . Pretreatment of tissues (n=4) with betaxolol abolished the contraction in response to salbutamol (not shown). and after preincubation in propranolol (n=5) or betaxolol (n=8) (2·10 -5 M). The concentration of the agonist eliciting minimum reaction was lower (3·10 -8 M) after preincubation in propranolol and betaxolol. Both antagonists inhibited the reaction to dobutamine in a noncompetitive manner, although they were not able to abolish the reaction. E max after propranolol pretreatment amounted to 1.161±0.167 mN (43.7% of the maximum reaction to dobutamine alone, p#0.0001), and with betaxolol was equal to 2.882±0.26 mN (47,11% of the maximum reaction to agonist alone, p#0.05). aorta to isoproterenol alone after preincubation in propranolol or betaxolol. Isoproterenol is characterized by low efficiency to induce contraction (E max =1.625±0.094 mN). Propranolol pretreatment induced stronger contractile reaction to isoproterenol at lower concentrations (10 -8 -10 -6 M) without influence on maximum reaction. Betaxolol strongly inhibited the contractile response to isoproterenol (E max =0.475±0.05 mN, 29.23% of the maximum response to agonist alone, p#0.05). 
Discussion
Administration of â-adrenergic receptor agonists induced the contractile response of the rabbit abdominal aorta strips, which most probably resulted from á-adrenergic receptor stimulation. The most pronounced reaction was observed after administration of dobutamine and the strength of the tissue response was similar to the case of phenylephrine administration (Fig. 1A) . Phenylephrine is the á 1 -agonist serving as a reference substance for aorta contractions (KENAKIN 1981) and was used as such in this study. The resulting increase in tonus after administration of dobutamine is consistent with the observations made by other researchers who proved that dobutamine acted as an á-agonist in the blood vessels (KENAKIN 1981) . Its (-)isomer is particularly effective in binding to and stimulating the á 1 -adrenergic receptor. A mixture of isomers is half as effective as the pure (-)isomer, as dobutamine (+)isomer binds to the á 1 -adrenergic receptor without stimulating it. Moreover, (+)isomer stimulates â 1 -adrenergic receptors which may affect the contractile response (RUF- FOLO et al. 1981) .
The contractile reaction after administration of isoproterenol was significantly weaker than the contraction induced by phenylephrine (á-agonist). Maximal contraction after isoproterenol accounted for 21.35% of the response to administration of phenylephrine at its highest concentration. These results are consistent with the literature data claiming that an isoproterenol concentration of 10 -7 to 10 -6 M induced the contractile response (FLEISCH et al. 1970) . Contraction following isoproterenol administration is blocked by prior incubation of the strips in phentolamine (á-antagonist), and the removal of endothelium, the main location of â-adrenergic receptors, intensifies the response (KAMATA et al. 1989; TURPAPATY et al. 1975) . This demonstrates the ability of isoproterenol to stimulate á-adrenergic receptors at higher concentrations.
The contractile reaction of rabbit aortic strips to salbutamol was equal to 15.26% of the response to phenylephrine. Salbutamol is considered to be a selective agonist of the â 2 -adrenergic receptor. Experimental results suggest that salbutamol may bind to á-adrenergic receptors at higher concentrations and slightly stimulate them. The possibility of salbutamol binding to the binding sites of the á-adrenergic receptors is also indicated by its ability to relax the strips precontracted with phenylephrine, and the lack of the relaxing effect on strips precontracted with PGF2á, thus indicating binding to á-adrenergic receptors (BRAHMADE-VARA et al. 2003; KOZ£OWSKA et al. 2005; SHAFIEI and MAHMOUDIAN 1999) . Antagonistic action towards strong agonists, such as phenylephrine, is typical of partial agonists. Additionally, studies with a radioligand demonstrated that salbutamol displaced 3 H-prazosin from its binding sites (BRAHMADEVARA et al. 2004) . However, the concentrations at which salbutamol induced the contraction of the aorta strips were much higher than clinical doses of the drug.
Similar results were obtained after administration of dobutamine which relaxed the aortic strips precontracted with phenylephrine, but did not affect the contraction induced by KCl or PGF 2á, and preincubation with dobutaminie affected the contractile response to phenylephrine without reducing the maximal response (AIKAWA et al. 1996) .
Preincubation of rabbit aorta strips with propranolol or betaxolol (2 · 10 -5 M) resulted in a reduction of the maximal response to both dobutamine and salbutamol. In the case of isoproterenol the maximal response was not statistically different for the strips incubated and not incubated with propranolol, whereas maximum reaction to isoproterenol after incubation with betaxolol was reduced. However, neither of the â-adrenergic receptor antagonists abolished the contractile reaction. Moreover, they did not influence the contraction of rabbit abdominal aorta in response to phenylephrine in our preliminary studies. In the case of isoproterenol and dobutamine propranolol and betaxolol induced the contractile response at lower concentration of agonists (10 -8 M). Propranolol has properties of a nonspecific â-adrenergic receptor antagonist. It inhibits vessel relaxation caused by isoproterenol and norepinephrine (AL JEBOORY & MARSHALL 1977; FUJIMOTO & ITOH 1996) . â 1 -antagonistic properties of betaxolol are also well established. Blocking â-adrenergic receptors may enhance the contractile response following the stimulation of á-adrenergic receptors, if an agonist showing affinity to both types of receptors is used. This situation occurs for contractions induced by norepinephrine. Propranolol, by blocking â-adrenergic receptors, increases the contractile response to norepinephrine (FUJIMOTO & ITOH 1996) . A similar phenomenon is observed for dobutamine and isoproterenol. The use of a â-adrenergic receptor blocker accelerated the occurrence of the contractile reaction; the contraction appears at lower concentrations and after a shorter period of time. However, a different tissue response occurred in the case of salbutamol. This might be related to a much weaker relaxation of the aortic strips precontracted with phenylephrine by salbutamol than isoproterenol (SHAFIEI & MAH-MOUDIAN 1999) . The desensitization of â-adrenergic receptors in the case of omitting the antagonist is rather unlikely, because aortic â 2 receptors have been shown to be insensitive to it (MARTIN & BROADLEY 1999 ).
Effect of â-Adrenergic Ligands on Rabbit Aorta
Propranolol and betaxolol inhibited the contractile response of tissues to higher concentrations of agonists. The response of the aortic strips to the highest concentration of isoproterenol was slightly lower after preincubation in propranolol, but this was not statistically significant. In contrast, betaxolol significantly inhibited the maximum response to isoproterenol. Both â-adrenergic receptor antagonists blunted the contractile reaction to high concentrations of dobutamine and salbutamol. EC 50 values were similar for both groups, so the competitive antagonism is rather unlikely the competitive antagonism. Maximum response to dobutamine was significantly reduced and amounted to less than 50% of the maximal response to dobutamine without antagonist preincubation, and it almost disappeared (14.77% of the maximal response to salbutamol without propranolol preincubation) or was entirely abolished (betaxolol) for salbutamol. This indicates a non-competitive antagonism. High concentrations of propranolol may limit the contractile response by binding to á 1 -adrenergic receptors without stimulating them. It was shown that propranolol displaced 3 H-prazosin from its binding site on á 1 -adrenergic receptor (BRAHMADEVARA et al. 2004) . However, this mechanism of inhibition is contradicted by the chart showing the course of the contractile reaction and indicating the non-competitive antagonism. In addition, in the case of strong binding of propranolol to á 1 -adrenergic receptors, the relaxation of strips precontracted with phenylephrine and then treated with dobutamine should be intensified, whereas a reverse phenomenon was observed (AIKAWA et al. 1996) . Moreover, a lack of influence on the phenylephrine contraction opposes antagonism of propranolol and betaxolol against á-adrenergic receptors. Still, it is certain that propranolol and betaxolol relax the blood vessels, irrespective of their effect on â-adrenergic receptors, as both substances similarly inhibited contraction elicited by â 1 -adrenergic and â 2 -adrenergic agonists (dobutamine and salbutamol, respectively). Moreover, inhibition of the contractile response to dobutamine and salbutamol by propranolol and betaxolol was comparable, despite differing selectivity towards â-adrenergic receptors. In experiments with phenylephrine used as a contracting agent, relaxation of rat aorta was observed following administration of high concentrations of propranolol. The role of á-adrenoreceptors in the relaxation response was excluded after administration of endothelin-1 and U-4619 as contracting substances. This was not entirely correct, because our team has shown the ability of á-antagonistic substances to relax human artery sections in vitro, without prior application of the á-adrenergic receptor agonist (GNUS et al. 2012; PRIVIERO et al. 2006) . Nevertheless, in the experiments of PRIVIERO et al.
higher concentrations of propranolol were used. Other possible mechanisms of propranolol action may involve membrane stabilizing activity, effect on calcium channels, inhibition of thromboxane A 2 production, and antagonistic activity at 5-HT 1 receptors (MARANO et al. 2002; SAKANASHI & TAKEO 1983; ORIJI & SCHANZ 2001; SAXENA & VILLALÓN 1990; CEKIC et al. 2013) . Propranolol and betaxolol were also equipotent in relaxing the bovine retinal microartery via a Ca 2+ channel blockade. Betaxolol was shown to relax the rat aorta and rabbit ciliary artery similar to calcium antagonists as well (HOSTE & SYS 1998; HAY-ASHI-MORIMOTO et al. 1999) . Many of the nonspecific characteristics of â-adrenergic receptor antagonists were evident only at high concentrations. In addition, experiments often require precontraction of the vessels. Phenylephrine, endothelin-1 and tromboxane A 2 analogues, which have high potency and efficacy, are typically used. It might be possible that the nonspecific properties of propranolol and betaxolol are more evident when applying a constrictor of low efficacy, which needs further investigation.
In conclusion, even highly selective agonists and antagonists of adrenergic receptors used in high doses can non-specifically bind to other groups of receptors. This should be kept in mind, especially during designing the experimental model. The use of á-agonists as a contracting agent may result in an inadequate tissue reaction to â-adrenergic substances.
